🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life

RecruitingNAAges 18 Years - anyAllLund University
NCT07141108 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Chronic pain impacts individuals, their families, and society significantly, yet specialist care resources are limited, with most patients managed in primary care. There is a need for tools that support self-management and improve resource allocation. This feasibility study evaluates the implementation of Paindrainer®, a CE-marked Class I digital tool, in primary care. Paindrainer® combines patient self-monitoring via an app with a healthcare provider portal (CARE) for remote monitoring. Using advanced neural networks, it offers personalized feedback to help patients plan and monitor daily activities and their impact on pain. The study aims to assess whether integrating this tool can enhance chronic pain management and patient quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Has pain that affects daily life and has lasted for more than 3 months Is over 18 years old Understands Swedish or English Is motivated and willing to use a digital tool for self-monitoring of activity level and symptoms Has no planned surgeries during the study period Has knowledge of and access to using a smartphone or tablet Exclusion Criteria: Severe or acute mental illness, severe anxiety, or depression Ongoing history of substance use disorder Serious illness under active treatment Pain related to malignancy Currently involved in legal proceedings or ongoing litigation related to low back or neck pain \-
💊

What it tests

  • Paindrainer Care system
📍

Where

1 site
Lunds Universitet Centrum för Primärvårdsforskning (CPF) Institutionen för kliniska vetenskaper, Malmö
Malmö, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy